Apologies for the misreading/misinterpretation.
Maybe the stem cell research teams already have enough excitementthis would just be too much.
Maybe the organisers want the revascularisation people to start thinking outside the box a little. Though this approach with MPC-150-IM would depend a bit on the urgency of the situation.
Ann: End-Stage HF Results Selected For AHA Scientific Sessions, page-51
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.5¢ |
Change
-0.040(3.98%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 94.0¢ | $5.111M | 5.283M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 184749 | 96.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.5¢ | 31188 | 9 |
View Market Depth
| Last trade - 11.24am 31/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |